BK7508 Pharmaceutical Companies
Not Yet Opened 11-26 16:00:00 AEDT
927.47
-4.98
-0.53%
High
934.71
Low
922.39
Vol
73.08M
Open
932.39
D1 Closing
932.45
Amplitude
1.32%
Mkt Cap
0.00
Tradable Cap
0.00
Total Shares
0.00
T/O
160.34M
T/O Rate
--
Tradable Shares
0.00
P/B
--
ROE
--
EPS
0.00
52wk High
--
52wk Low
--
P/E
--
Dividend
--
Div.Yield
--
ROA
--
Time
5D
D
W
M
News
New Post(s)
Profile
Genetic Technologies Ltd-Entitlement Offer Update - Refund of Application Monies
THOMSON REUTERS · 15:21
Genetic Technologies Ltd-Entitlement Offer Update - Refund of Application Monies
Respiri to Acquire US Healthcare Service Provider for $9 million
MT Newswires Live · 14:34
Respiri to Acquire US Healthcare Service Provider for $9 million
ASX Growth Companies With High Insider Ownership In November 2024
Simply Wall St. · 12:05
ASX Growth Companies With High Insider Ownership In November 2024
3 ASX healthcare shares surging on big news
MotleyFool · 08:32
3 ASX healthcare shares surging on big news
BUZZ-Australia's Respiri rises on buying US-based Orb Health
Reuters · 08:21
BUZZ-Australia's Respiri rises on buying US-based Orb Health
PolyNovo's Share-Price Retreat Creates Buying Opportunity -- Market Talk
Dow Jones · 07:11
PolyNovo's Share-Price Retreat Creates Buying Opportunity -- Market Talk
Discover Alto Metals And 2 More Exciting Penny Stocks On The ASX
Simply Wall St. · 07:05
Discover Alto Metals And 2 More Exciting Penny Stocks On The ASX
BRIEF-Respiri Signs Binding Purchase Agreement With ORB Health
Reuters · 06:34
BRIEF-Respiri Signs Binding Purchase Agreement With ORB Health
The pros and cons of buying CSL shares right now
MotleyFool · 06:33
The pros and cons of buying CSL shares right now
Respiri Ltd - for an Initial Purchase Price of US$9 Mln
THOMSON REUTERS · 06:31
Respiri Ltd - for an Initial Purchase Price of US$9 Mln
Respiri Ltd - Signs Binding Purchase Agreement With Orb Health With US$4.2M in Revenues
THOMSON REUTERS · 06:31
Respiri Ltd - Signs Binding Purchase Agreement With Orb Health With US$4.2M in Revenues
Respiri Ltd - Acquisition Is Expected to Generate Synergies Totaling Approximately a$3.5 Mln During Full 12 Months of Ops
THOMSON REUTERS · 06:31
Respiri Ltd - Acquisition Is Expected to Generate Synergies Totaling Approximately a$3.5 Mln During Full 12 Months of Ops
Why did this ASX biotech stock explode 52% higher on Monday?
MotleyFool · 11-25 14:21
Why did this ASX biotech stock explode 52% higher on Monday?
Here are the top 10 ASX 200 shares today
MotleyFool · 11-25 14:12
Here are the top 10 ASX 200 shares today
Australian shares log record closing high on healthcare, IT boost
Reuters · 11-25 14:12
Australian shares log record closing high on healthcare, IT boost
3 ASX Growth Stocks To Watch With Up To 27% Insider Stake
Simply Wall St. · 11-25 12:01
3 ASX Growth Stocks To Watch With Up To 27% Insider Stake
ASX 200 raises the record AGAIN. Which stocks are 'cheaper' than the index?
MotleyFool · 11-25 10:41
ASX 200 raises the record AGAIN. Which stocks are 'cheaper' than the index?
Invest $10,000 into these Australian shares in December
MotleyFool · 11-25 06:13
Invest $10,000 into these Australian shares in December
Could these 2 stocks become the ASX's next 10-baggers?
LiveWire · 11-25 04:00
Could these 2 stocks become the ASX's next 10-baggers?
<em>This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game </em>
The Market Herald · 11-25 00:00
<em>This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game </em>
Load more
Introduction
Company Name.
BK7508
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--
{"stockData":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":927.47394,"timestamp":1732597199837,"preClose":932.4526,"halted":0,"volume":73083212,"delay":0,"changeRate":-0.005339,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-4.978638,"latestTime":"11-26 16:00:00 AEDT","open":932.39246,"high":934.7119,"low":922.3866,"amount":160338690,"amplitude":0.013218,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1732662000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1732575600000,1732597200000]],"turnoverRate":0.00198,"increases":14,"decrements":17,"flats":13,"marketCap":146398223592.34375,"floatMarketCap":143710875556.1875},"requestUrl":"/m/hq/s/BK7508","defaultTab":"news","newsList":[{"id":"2486419560","title":"Genetic Technologies Ltd-Entitlement Offer Update - Refund of Application Monies","url":"https://stock-news.laohu8.com/highlight/detail?id=2486419560","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486419560?lang=en_us&edition=fundamental","pubTime":"2024-11-26 15:21","pubTimestamp":1732605719,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nTUE24BDXT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","GTG.AU","BK7508"],"gpt_icon":0},{"id":"2486045687","title":"Respiri to Acquire US Healthcare Service Provider for $9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2486045687","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486045687?lang=en_us&edition=fundamental","pubTime":"2024-11-26 14:34","pubTimestamp":1732602892,"startTime":"0","endTime":"0","summary":"Respiri has entered an agreement to acquire Texas-based healthcare service provider Orb Health for $9 million through the issue of shares, according to a Tuesday filing with the Australian bourse.The deal includes potential additional payments based on Orb Health's financial performance in 2025 through the issue of additional shares, the filing said.Under the agreement, Orb Health will also invest AU$1.1 million by subscribing for additional fully paid ordinary shares. Orb Health's Annual Recurring Revenues for 2024 are expected to be $4.2 million.The acquisition is anticipated to generate AU$3.5 million in synergies and over AU$2 million in cross-selling opportunities during the first 12 months of operations, the filing added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7503","BK7095","HCSG","BK4110","BK7007","BK4137","BK7508","ARR","RSH.AU","ARR.AU"],"gpt_icon":0},{"id":"2486901902","title":"ASX Growth Companies With High Insider Ownership In November 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2486901902","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486901902?lang=en_us&edition=fundamental","pubTime":"2024-11-26 12:05","pubTimestamp":1732593955,"startTime":"0","endTime":"0","summary":"The Australian market has shown some volatility with the ASX200 slightly down at 8,385 points, amid global trade tensions sparked by President-elect Donald Trump's tariff announcements. In this fluctuating environment, growth companies with high insider ownership can be appealing as they often indicate strong confidence from those closely involved in the business.Top 10 Growth Companies With High Insider Ownership In Australia. Click here to see the full list of 93 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Overview: Duratec Limited, along with its subsidiaries, provides assessment, protection, remediation, and refurbishment services for steel and concrete infrastructure assets in Australia, with a market cap of A$384.36 million.Overview: Develop Global Limited, with a market cap of A$534.71 million, is involved in the exploration and development of mineral resource properties in Australia through its subsidiaries.Develop Global exhibits strong grow","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kpZnHWmVXh9fa.5MJ5otJg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/e18325c660d04f2fe88569956b7babe1","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kpZnHWmVXh9fa.5MJ5otJg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/e18325c660d04f2fe88569956b7babe1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-growth-companies-high-insider-040555274.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7016","AVA.AU","BK7023","XKO.AU","FND.AU","BK7116","CYL.AU","BK7055","PLT.AU","HGO.AU","3DP.AU","BK7084","BK7137","BK7158","BK7508","SKS.AU","BK7043","BK7506","NWF.AU","BK7095","DVP.AU","BK7104","DUR.AU","GYG.AU","XJO.AU","BTR.AU","ACR.AU","XAO.AU","BK7093","BK7096"],"gpt_icon":0},{"id":"2486096270","title":"3 ASX healthcare shares surging on big news","url":"https://stock-news.laohu8.com/highlight/detail?id=2486096270","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486096270?lang=en_us&edition=fundamental","pubTime":"2024-11-26 08:32","pubTimestamp":1732581120,"startTime":"0","endTime":"0","summary":"ASX healthcare shares are higher in early trading on Tuesday, with theS&P/ASX 200 Health Care Index up 0.34% while the broaderS&P/ASX All Ordinaries Index is down 0.18%. These 3 ASX healthcare shares are among the strongest performers within the sector today. Let's find out why. Why are these ASX healthcare shares ripping today?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/11/26/3-asx-healthcare-shares-surging-on-big-news/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7095","BK7503","REG.AU","AGM","ARR","BK7508","CU6.AU","BK4110","XAO.AU","RSH.AU","BK7007","AGM.AU","BK4195","ARR.AU","BK4229","BK7096","BK7113"],"gpt_icon":0},{"id":"2486409871","title":"BUZZ-Australia's Respiri rises on buying US-based Orb Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2486409871","media":"Reuters","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486409871?lang=en_us&edition=fundamental","pubTime":"2024-11-26 08:21","pubTimestamp":1732580491,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Respiri rises on buying US-based Orb Health** Shares of Respiri RSH.AX rise as much as 7.5% to A$0.086** e-health software services provider signs binding purchase agreement to buy U.S.-based connected care organisation Orb Health Inc for $9 mln** Expects acquisition to generate synergies totalling ~A$3.5 mln in the initial full 12 months of operations** About 2.6 shares traded, 1.2x the 30-day avg** RSH has more than doubled YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nL3N3MX00X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7503","RSH.AU","BK7007"],"gpt_icon":0},{"id":"2486062333","title":"PolyNovo's Share-Price Retreat Creates Buying Opportunity -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2486062333","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486062333?lang=en_us&edition=fundamental","pubTime":"2024-11-26 07:11","pubTimestamp":1732576260,"startTime":"0","endTime":"0","summary":"2311 GMT - Morgans senses a buying opportunity in skin-healing tech developer PolyNovo. The stock has fallen roughly 25% since the end of September, which analyst Scott Power thinks is partly because PolyNovo didn't give a trading update at its annual meeting of shareholders. \"Consensus has revenue growth of 29% for FY 2025 which will be skewed to the 2H and we are confident it can be achieved,\" Morgans says. \"Growth of 20%+ is expected to continue in FY26/27 driven by regional expansion as well as additional indications.\" Morgans has a A$2.85/share price target and add call on PolyNovo, which ended Monday at A$2.04. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7126","PNV.AU"],"gpt_icon":0},{"id":"2486067898","title":"Discover Alto Metals And 2 More Exciting Penny Stocks On The ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2486067898","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486067898?lang=en_us&edition=fundamental","pubTime":"2024-11-26 07:05","pubTimestamp":1732575908,"startTime":"0","endTime":"0","summary":"The Australian market is poised for a modest rise, buoyed by positive developments on Wall Street and reports of a potential Middle East ceasefire. Amidst these broader market movements, investors often look to smaller or newer companies for unique opportunities. Penny stocks, despite their somewhat outdated name, can still offer significant value when backed by strong financials. In this article, we explore three such penny stocks on the ASX that combine balance sheet strength with the potential for notable growth.Click here to see the full list of 1,046 stocks from our ASX Penny Stocks screener.Overview: Alto Metals Limited focuses on the exploration of gold properties in Western Australia and has a market cap of A$66.38 million.Explore historical data to track Alto Metals' performance over time in our past results report.Overview: Mayne Pharma Group Limited is a specialty pharmaceutical company that manufactures and sells branded and generic pharmaceutical products across Australia,","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/q0yRN_h1fYD6SjjSkWx5lg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4afa9747177650711578ccd57242a6b7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/q0yRN_h1fYD6SjjSkWx5lg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4afa9747177650711578ccd57242a6b7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/discover-alto-metals-2-more-230508692.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["XAO.AU","BK7508","BK7088","LBL.AU","XJO.AU","NGI.AU","BK7045","EZZ.AU","BK7070","AME.AU","LU0106831901.USD","LU1791807156.HKD","BK7132","ANG.AU","BK7502","BK4166","BK7048","LU1861220207.SGD","BK7104","MYX.AU","BK7131","XKO.AU","BK4585","LU2360107671.USD","BK7077","HLO.AU","VLS.AU","BK4588","BK7062","ATP.AU","DFS","EVO.AU","LU1668664300.SGD","SHA.AU","XRF.AU","GTN.AU","LU1861217088.USD","BK7096","BK7055"],"gpt_icon":0},{"id":"2486548061","title":"BRIEF-Respiri Signs Binding Purchase Agreement With ORB Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2486548061","media":"Reuters","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486548061?lang=en_us&edition=fundamental","pubTime":"2024-11-26 06:34","pubTimestamp":1732574095,"startTime":"0","endTime":"0","summary":"BRIEF-Respiri Signs Binding Purchase Agreement With ORB HealthNov 26 - Respiri Ltd RSH.AX:SIGNS BINDING PURCHASE AGREEMENT WITH ORB HEALTH WITH US$4.2M IN REVENUESFOR AN INITIAL PURCHASE PRICE OF US$9 MILLIONACQUISITION IS EXPECTED TO GENERATE SYNERGIES TOTALING APPROXIMATELY A$3.5 MILLION DURING FULL 12 MONTHS OF OPERATIONSFurther company coverage: RSH.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241125:nFWN3MW0ZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7503","RSH.AU","BK7007","BK7508"],"gpt_icon":0},{"id":"2486626820","title":"The pros and cons of buying CSL shares right now","url":"https://stock-news.laohu8.com/highlight/detail?id=2486626820","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486626820?lang=en_us&edition=fundamental","pubTime":"2024-11-26 06:33","pubTimestamp":1732574019,"startTime":"0","endTime":"0","summary":"CSL Ltd (ASX: CSL) shares have drifted lower over the last few months. The ASX healthcare share has dropped around 10% since July 2024, while the S&P/ASX 200 Index (ASX: XJO) has gone up more than 5% ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/11/26/the-pros-and-cons-of-buying-csl-shares-right-now/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["CSL","SG9999004303.SGD","BK7511","BK7508","BK4086","LU1169590202.USD","BK7501","LU0728928796.USD","SGXZ23171101.USD","XJO.AU","LU1169589451.USD","CSL.AU","BK7067"],"gpt_icon":0},{"id":"2486206908","title":"Respiri Ltd - for an Initial Purchase Price of US$9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2486206908","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486206908?lang=en_us&edition=fundamental","pubTime":"2024-11-26 06:31","pubTimestamp":1732573872,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241125:nFWN3MW0ZB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","RSH.AU","BK7503","BK7007"],"gpt_icon":0},{"id":"2486069081","title":"Respiri Ltd - Signs Binding Purchase Agreement With Orb Health With US$4.2M in Revenues","url":"https://stock-news.laohu8.com/highlight/detail?id=2486069081","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486069081?lang=en_us&edition=fundamental","pubTime":"2024-11-26 06:31","pubTimestamp":1732573872,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241125:nFWN3MW0ZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","BK7503","BK7508","RSH.AU"],"gpt_icon":0},{"id":"2486069058","title":"Respiri Ltd - Acquisition Is Expected to Generate Synergies Totaling Approximately a$3.5 Mln During Full 12 Months of Ops","url":"https://stock-news.laohu8.com/highlight/detail?id=2486069058","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486069058?lang=en_us&edition=fundamental","pubTime":"2024-11-26 06:31","pubTimestamp":1732573872,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241125:nFWN3MW0ZB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","RSH.AU","BK7007","BK7503"],"gpt_icon":0},{"id":"2486736776","title":"Why did this ASX biotech stock explode 52% higher on Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2486736776","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486736776?lang=en_us&edition=fundamental","pubTime":"2024-11-25 14:21","pubTimestamp":1732515686,"startTime":"0","endTime":"0","summary":"Paradigm Biopharmaceuticals Ltd shares started the week with an almighty bang. The ASX biotech stock ended the session almost 42% higher at 46 cents. At one stage, the biopharmaceutical company's shares were up as much as 52% to a 52-week high of 49.5 cents. Why did this ASX biotech stock rocket?Investors were bidding the company's shares higher today despite there being no news out of it. Though, interestingly, the lack of news was arguably the trigger for this rampant buying, with investors deeming no news to be very good news. The buying was so strong that it even led to the Australian stock exchange operator giving the ASX biotech stock a speeding ticket. It said: Is PAR aware of any information concerning it that has not been announced to the market which, if known by some in the market, could explain the recent trading in its securities?In response, the biotech said: No, the Company is not aware of any information concerning it that has not been announced to the market which, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/11/25/why-did-this-asx-biotech-stock-explode-52-higher-on-monday/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["TGA.AU","XKO.AU","BK4213","XJO.AU","BK7508","BK7067","XAO.AU","TGA","PAR.AU","BK7001"],"gpt_icon":0},{"id":"2486270467","title":"Here are the top 10 ASX 200 shares today","url":"https://stock-news.laohu8.com/highlight/detail?id=2486270467","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486270467?lang=en_us&edition=fundamental","pubTime":"2024-11-25 14:12","pubTimestamp":1732515176,"startTime":"0","endTime":"0","summary":"It was a bullish start to the trading week for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares this Monday, with the markets hitting another new all-time record high. After ending last week on a ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/11/25/here-are-the-top-10-asx-200-shares-today-539/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7005","BK7087","ZIP.AU","BK7103","BK7093","BK7144","BK7012","BK7095","BK7504","BK7162","BK7137","BK7126","MGR.AU","INA.AU","GYG.AU","BK7016","BK7510","SIG.AU","XJO.AU","360.AU","BK7159","SCG.AU","FBU.AU","LTR.AU","BK7508","PNV.AU"],"gpt_icon":1},{"id":"2486731727","title":"Australian shares log record closing high on healthcare, IT boost","url":"https://stock-news.laohu8.com/highlight/detail?id=2486731727","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486731727?lang=en_us&edition=fundamental","pubTime":"2024-11-25 14:12","pubTimestamp":1732515146,"startTime":"0","endTime":"0","summary":"Australian shares log record closing high on healthcare, IT boostAustralia inflation data due later in the weekNew Zealand stocks hit level unseen since Oct 2021New Zealand cenbank expected to cut rates on WednesdayUpdates to closeBy Adwitiya Srivastava","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241125:nL3N3MW09V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","CBA.AU","BK7135","ANZ.AU","BK7511","BK7508","BK7067","BK7501","WBC.AU"],"gpt_icon":1},{"id":"2486172664","title":"3 ASX Growth Stocks To Watch With Up To 27% Insider Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2486172664","media":"Simply Wall St.","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486172664?lang=en_us&edition=fundamental","pubTime":"2024-11-25 12:01","pubTimestamp":1732507290,"startTime":"0","endTime":"0","summary":"As the ASX200 edges up 0.7% after reaching a new all-time intra-day high, investor attention is focused on whether it will close at record levels, with sectors like Real Estate and Discretionary leading the charge. In this buoyant environment, growth companies with significant insider ownership can be particularly appealing as they often indicate strong internal confidence and alignment with shareholder interests.Top 10 Growth Companies With High Insider Ownership In Australia. Click here to see the full list of 90 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Overview: Chrysos Corporation Limited develops and supplies mining technology, with a market cap of A$573.47 million.Catalyst Metals is positioned for substantial growth, with earnings projected to rise 33.1% annually, surpassing the Australian market's average. Despite past shareholder dilution, it became profitable this year and its revenue growth forecast of 21.2% per year exceeds market expec","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/UrHBsIrR8XWjKtdqSp2vkw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b3b5a2748dbe57dca97087f8af8726d5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/UrHBsIrR8XWjKtdqSp2vkw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b3b5a2748dbe57dca97087f8af8726d5"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-asx-growth-stocks-watch-040130756.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7096","BK7506","SKS.AU","HGO.AU","QAL.AU","BK7508","NWF.AU","BK7050","BTR.AU","XKO.AU","C79.AU","ACR.AU","XJO.AU","BK7016","XAO.AU","3DP.AU","BK7062","BK7104","MM8.AU","BK7095","BK7116","AVA.AU","BK7158","CYL.AU","BK7121","BK7064","PLT.AU","BK7093","BK7084","BK7043","BK7023","FND.AU"],"gpt_icon":1},{"id":"2486740996","title":"ASX 200 raises the record AGAIN. Which stocks are 'cheaper' than the index?","url":"https://stock-news.laohu8.com/highlight/detail?id=2486740996","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486740996?lang=en_us&edition=fundamental","pubTime":"2024-11-25 10:41","pubTimestamp":1732502475,"startTime":"0","endTime":"0","summary":"The S&P/ASX 200 Index is knocking on the door of another all-time high, bringing gains to more than 11% for the year to date. But the index is also at a frothy valuation when compared to the earnings of the underlying businesses that comprise its makeup. More so when compared to history. Starting valuations matter – a lot. They are perhaps one of the most critical parts of investing over the long term. Consequently, investors may be searching for names within the ASX 200 that present more attractive prices. Let's take a look. What's driving the ASX 200 higher?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/11/25/asx-200-raises-the-record-again-which-stocks-are-cheaper-than-the-index/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["KAR.AU","BK7506","BK7505","BK7117","BK7508","BK7062","BK7135","BK7067","JBH.AU","BK7137","BK7142","BK7001","CBA.AU","CKF.AU","IEL.AU","BK7104","PRU.AU","FMG.AU","BK7160","BK7083","BK7123","MFG.AU","BHP.AU","ELD.AU","BK7095","BK7511","CSL.AU","HLI.AU","SMR.AU","XJO.AU","BK7132","BK7507","BK7509","BK7501","BK7129","YAL.AU"],"gpt_icon":1},{"id":"2486140177","title":"Invest $10,000 into these Australian shares in December","url":"https://stock-news.laohu8.com/highlight/detail?id=2486140177","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486140177?lang=en_us&edition=fundamental","pubTime":"2024-11-25 06:13","pubTimestamp":1732486382,"startTime":"0","endTime":"0","summary":"Do you have $10,000 burning a hole in your pocket?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/11/25/invest-10000-into-these-australian-shares-in-december/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7049","BK7508","XJO.AU","BK7107","BK7067","BK7511","BK7043","CSL.AU","XAO.AU","BK7501","XKO.AU","TPW.AU","NXT.AU","BK7503"],"gpt_icon":1},{"id":"2486107715","title":"Could these 2 stocks become the ASX's next 10-baggers?","url":"https://stock-news.laohu8.com/highlight/detail?id=2486107715","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486107715?lang=en_us&edition=fundamental","pubTime":"2024-11-25 04:00","pubTimestamp":1732478438,"startTime":"0","endTime":"0","summary":"Ahh, the mystical 10-bagger. A stock that has delivered its investors a 10x return on their initial investment. Initially coined by legendary investor Peter Lynch, who was a fan of discovering undervalued stocks with sustainable and attractive earnings per share growth, a love of 10-baggers saw Lynch's Magellan Fund achieve a 29.2% average return over the 13 years he managed it.In his book, One Up on Wall Street, Lynch wrote, “In my business a four-bagger is nice, but a ten-bagger is the fiscal equivalent of two home runs and a double.”While this anonymous writer may not know anything about sports, I do know a few talented local fund managers who can help investors identify the ASX's next great 10-baggers.So, in this episode, Livewire's Ally Selbywas joined by Ausbil's Andrew Perosand Ellerston's David Keelan. They share their secrets to identifying long-term compounders, the importance of backing strong founders, the red flags investors should look out for, and whether profitless comp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/could-these-2-stocks-become-the-asx-s-next-10-baggers","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/could-these-2-stocks-become-the-asx-s-next-10-baggers","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7503","BK7501","BK7002","BK7033","PME.AU","VEE.AU","BK7511","LIF","SQ2.AU","HUB.AU","BK7508","BK4023","BK7051","BK7129","BK7067","CAT.AU","360.AU","CSL.AU","BK7016","BK7507","REA.AU","BK7104","BK7505","TAM.AU","BK7094","BK7141","BK7158","A2M.AU","BK7088","PWH.AU","BK7084","FMG.AU","TLX.AU","BK7054"],"gpt_icon":0},{"id":"2486792724","title":"<em>This biotech stock raised $11M in a risk-off environment. Its Alzheimer’s drug could change the game </em>","url":"https://stock-news.laohu8.com/highlight/detail?id=2486792724","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486792724?lang=en_us&edition=fundamental","pubTime":"2024-11-25 00:00","pubTimestamp":1732464000,"startTime":"0","endTime":"0","summary":"For years, people dreamed that science would one day create a pill to cure all ills.Today, one small pill may not cure everything, but it holds the potential to transform cognitive medicine by addressing debilitating conditions like depression and Alzheimer’s.This is the promise of Xanamem, a breakthrough from Actinogen Medical that could improve the lives of millions in Australia and around the world.Depression and Alzheimer’s are among the most widespread mental health challenges in Australia, affecting countless individuals and families. Decades of research has highlighted a link between these conditions and cortisol—a hormone related to stress.Actinogen’s Xanamem is the first medication that can control brain tissue cortisol without affecting normal levels of cortisol needed in the rest of the body.Xanamem provides a novel approach to managing depression, known as the “black dog,” and for slowing Alzheimer’s progression.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/this-biotech-stock-raised-11m-in-a-risk-off-environment-its-alzheimers-drug-could-change-the-game-2024-11-25/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["XKO.AU","BK7067","XAO.AU","BK7508","XJO.AU","ACW.AU"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0091},{"period":"1month","weight":-0.0106},{"period":"3month","weight":-0.0169},{"period":"6month","weight":0.0382},{"period":"1year","weight":0.1487},{"period":"ytd","weight":0.1373}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"name":"BK7508","nameEN":"BK7508"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmaceutical Companies(BK7508) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmaceutical Companies,BK7508,Pharmaceutical Companies股票,Pharmaceutical Companies股票老虎,Pharmaceutical Companies股票老虎国际,Pharmaceutical Companies行情,Pharmaceutical Companies股票行情,Pharmaceutical Companies股价,Pharmaceutical Companies股市,Pharmaceutical Companies股票价格,Pharmaceutical Companies股票交易,Pharmaceutical Companies股票购买,Pharmaceutical Companies股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmaceutical Companies(BK7508) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}